Harbert Fund Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,500
Closed -$510K 111
2024
Q3
$510K Buy
3,500
+1,650
+89% +$239K 0.3% 71
2024
Q2
$254K Buy
+1,850
New +$247K 0.18% 84

Other funds holding IBB

Harbert Fund Advisors's IBB Position: Q4 2024 in Review

Harbert Fund Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 3,500 shares — an estimated $510K sold.

Harbert Fund Advisors first reported a position in IBB in Q2 2024 and held it in 2 quarters. The position peaked at $510K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Harbert Fund Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Harbert Fund Advisors sold 3,500 iShares Biotechnology ETF shares in Q4 2024, an estimated $510K.
  • Harbert Fund Advisors first reported a position in iShares Biotechnology ETF in Q2 2024 and held it in 2 quarters.
  • Harbert Fund Advisors's iShares Biotechnology ETF position peaked at $510K in Q3 2024.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Harbert Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.